Relapsed/refractory Burkitt lymphoma and HIV infection.

about

Relapsed/refractory Burkitt lymphoma and HIV infection.

Item

http://www.wikidata.org/entity/Q47562321

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Relapsed/refractory Burkitt lymphoma and HIV infection.

@en

Relapsed/refractory Burkitt lymphoma and HIV infection.

@nl

type

Item

label

Relapsed/refractory Burkitt lymphoma and HIV infection.

@en

Relapsed/refractory Burkitt lymphoma and HIV infection.

@nl

prefLabel

Relapsed/refractory Burkitt lymphoma and HIV infection.

@en

Relapsed/refractory Burkitt lymphoma and HIV infection.

@nl

P1476

Relapsed/refractory Burkitt lymphoma and HIV infection

@en

P2093

Alina Khan

http://www.w3.org/2001/XMLSchema#string

Marco Ruiz

http://www.w3.org/2001/XMLSchema#string

Neil Nagovski

http://www.w3.org/2001/XMLSchema#string

P2860

BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects

Targeting MYC dependence in cancer by inhibiting BET bromodomains

Burkitt lymphoma in adolescents and young adults: management challenges.

Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantat

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.

Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma.

High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program.

A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.

P304

695-703

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1177/0956462417748239

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amanda Brahim

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29264956

http://www.w3.org/2001/XMLSchema#string

P921

Burkitt lymphoma